SMTL ID : 5udc.1

Crystal Structure of RSV F A2 Bound to MEDI8897

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 3.45 Å
Oligo State
hetero-3-3-3-mer
Ligands
1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
2 x CL: CHLORIDE ION(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Zhu, Q. et al., A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants. Sci Transl Med (2017)
Release Date
2017-05-17
Peptides
MEDI8897 Fab Heavy Chain: ADG
MEDI8897 Fab Light Chain: BEH
Fusion glycoprotein F0: CFI
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
H
D
B
G
E
B
L
E
C
H
G
C
F
F
A
I
D

MEDI8897 Fab Heavy Chain

MEDI8897 Fab Light Chain

Toggle Identical (BE)

Fusion glycoprotein F0

Related Entries With Identical Sequence

4jha.1 | 4jhw.1 | 5ea3.1 | 5ea4.1 | 5ea5.1 | 5ea6.1 | 5ea7.1 | 5kww.1 | 5udd.1 | 5udd.2 | 5udd.3 | 6dc3.1 | 6dc5.1 | 6dc5.2 | 6dc5.3 | 6vkc.1 | 6vkd.1 | 6vke.1 | 7kqd.1